Leonurine Sulfate

硫酸益母草碱

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameLeonurine Sulfate
Drug Alias NameSCM-198
ClassificationNatural product/Extract
Mechanisms of ActionNADPH oxidase 4 modulators
TargetsNADPH oxidase 4
Therapy Area/IndicationsHyperlipidemiasAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsHyperlipidemiasAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A